Clearline Capital LP Lensar, Inc. Transaction History

Clearline Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.2 - $8.82 $492,878 - $1.04 Million	-117,352 Reduced 67.83%	55,652 $490,000
Q4 2023 Feb 14, 2024	BUY	$2.01 - $3.51 $114,551 - $200,038	56,991 Added 49.12%	173,004 $607,000
Q2 2023 Aug 14, 2023	BUY	$2.3 - $4.34 $145,044 - $273,693	63,063 Added 119.1%	116,013 $493,000
Q4 2021 Feb 14, 2022	BUY	$5.9 - $7.84 $312,405 - $415,128	52,950 New	52,950 $317,000

5.23M

46.9K

24K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $142M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.